REGN vs STEP
Regeneron Pharmaceuticals Inc (REGN) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported STEP revenue for 2025-03-31 was $1.17B. Net income was -$172.8M. Revenue was up 65.1% from 2024-03-31 to 2025-03-31. STEP currently screens at market cap $5.78B.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. STEP currently screens at market cap $5.78B.
Not investment advice. Open the REGN and STEP stock pages for the full models.
Not investment advice.